BioengineeringbioRxivPreprint
Conversion of a Viral Glycan Shield into a Binding Anchor via Causal-Driven Antibody Optimization
X T Wang, Guanying Zhang, Mingda Hu…·Xiangyang Chi
This paper develops AENCS to engineer antibodies targeting glycosylated epitopes, demonstrating ACC01's 24-fold improved neutralization against SARS-CoV-2 variants.
DOI 10.64898/2026.06.25.734658